Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1857P - Oncology dedicated emergency department: Patient delineation and utility of care: A retrospective study


17 Sep 2020


E-Poster Display


Supportive Care and Symptom Management

Tumour Site


Ilit Turgeman


Annals of Oncology (2020) 31 (suppl_4): S988-S1017. 10.1016/annonc/annonc291


I. Turgeman1, G. Bar-Sela2

Author affiliations

  • 1 Oncology Dept., Rambam Health Care Center, 3109601 - Haifa/IL
  • 2 Oncology, Emek Medical Center, 18101 - Afula/IL


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1857P


Emergency care in oncology constitutes a significant burden for both patients and the healthcare system. The purpose of this study was to correlate clinical characteristics of patients with effective treatment in an oncology-dedicated emergency department (OED), as compared with a general emergency department (GED).


Electronic files of cancer patients who visited the OED and GED between April - June 2017 were retrospectively collected from the hospital registry, and efficacy parameters were compared between groups. Data obtained from a representative sample of patients in the OED were analyzed using descriptive statistics and logistic regressions to determine which factors were associated with successful or insufficient management in the OED alone.


The full cohort included 799 patients treated in both emergency settings. A total of 479 patients (60%) presented initially to the OED, and of these, 50 (10.4%) required referral to the GED. Compared with the OED, treatment in the GED was significantly associated with more consultations, imaging and hospitalizations (88% vs 16% p<0.001). In the OED, most patients were male and above age 60. Common diagnoses were lung (33%) gastrointestinal (30%) and breast (11%) cancer; 85% were metastatic. Treatment modalities included chemotherapy (59%), immunotherapy (16%) and biologics (16%). Pain was the most frequent chief complaint (45%), followed by gastrointestinal (33%), malaise (18%) and respiratory (15%). Most admissions were for management of disease symptoms (30%) and treatment side effects (18%). Characteristics associated higher referral to the GED included genitourinary cancer (56% p=0.031), biological therapy (64% p<0.001), back pain (80% p<0.001), neurological (60% p=0.010), and suspected oncological emergencies (79% p<0.001). Conversely, disease symptoms were well controlled in the OED (86% p=0.003), as treatment side effects and minor procedures.


The OED provides convenient, efficacious, cancer focused care. However, careful triage of patients is recommended, as diagnosis, symptoms, and admission type can predict referral to the GED. High-risk patients should avoid admission to the OED, which is better suited for urgent than emergent care.

Clinical trial identification

0465-17-RMB IRB approval granted November 12, 2017 Extended until December 13, 2020.

Editorial acknowledgement

Legal entity responsible for the study

The authors.


Friends of Rambam NPO.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.